Secretion of cartilage oligomeric matrix protein is affected by the signal peptide

被引:25
作者
Holden, P
Keene, DR
Lunstrum, GP
Bächinger, HP
Horton, WA
机构
[1] Shriners Hosp Children, Res Ctr, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA
关键词
D O I
10.1074/jbc.M411716200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cartilage oligomeric matrix protein ( COMP) is a secreted glycoprotein found in the extracellular matrices of skeletal tissues. Mutations associated with two human skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia, disturb COMP secretion leading to intracellular accumulation of mutant COMP, especially in chondrocytes. Here we show that the manifestation of this secretory defect is dramatically influenced by the signal peptide that targets COMP for secretion. The comparison of wild type and mutant COMP secretion directed by the COMP or BM40 signal peptide in HEK-293 cells and rat chondrosarcoma cells revealed that the BM40 signal peptide substantially enhances secretion of mutant COMP that accumulates in endoplasmic reticulum-like structures when targeted by its own signal peptide. Additionally, we demonstrate that mutant COMP forms mixed pentamers with wild type COMP. Our findings suggest that the secretory defect in pseudoachondroplasia and multiple epiphyseal dysplasia is not specific for chondrocytes, nor does it require interaction of mutant COMP with other matrix proteins prior to transport from the cell. They also imply a previously unappreciated role for the signal peptide in the regulation of protein secretion beyond targeting to the endoplasmic reticulum.
引用
收藏
页码:17172 / 17179
页数:8
相关论文
共 56 条
[1]  
BIRD P, 1990, J BIOL CHEM, V265, P8420
[2]   Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia multiple epiphyseal dysplasia disease spectrum [J].
Briggs, MD ;
Mortier, GR ;
Cole, WG ;
King, LM ;
Golik, SS ;
Bonaventure, J ;
Nuytinck, L ;
De Paepe, A ;
Leroy, JG ;
Biesecker, L ;
Lipson, M ;
Wilcox, WR ;
Lachman, RS ;
Rimoin, DL ;
Knowlton, RG ;
Cohn, DH .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :311-319
[3]   Pseudoachondroplasia and multiple epiphyseal dysplasia: Mutation review, molecular interactions, and genotype to phenotype correlations [J].
Briggs, MD ;
Chapman, KL .
HUMAN MUTATION, 2002, 19 (05) :465-478
[4]   PSEUDOACHONDROPLASIA AND MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO MUTATIONS IN THE CARTILAGE OLIGOMERIC MATRIX PROTEIN GENE [J].
BRIGGS, MD ;
HOFFMAN, SMG ;
KING, LM ;
OLSEN, AS ;
MOHRENWEISER, H ;
LEROY, JG ;
MORTIER, GR ;
RIMOIN, DL ;
LACHMAN, RS ;
GAINES, ES ;
CEKLENIAK, JA ;
KNOWLTON, RG ;
COHN, DH .
NATURE GENETICS, 1995, 10 (03) :330-336
[5]   Calcium dynamics and endoplasmic reticular function in the regulation of protein synthesis: implications for cell growth and adaptability [J].
Brostrom, MA ;
Brostrom, CO .
CELL CALCIUM, 2003, 34 (4-5) :345-363
[6]   Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes [J].
Chen, H ;
Deere, M ;
Hecht, JT ;
Lawler, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26538-26544
[7]   Col2-GFP reporter mouse -: A new tool to study skeletal development [J].
Cho, JY ;
Grant, TD ;
Lunstrum, GP ;
Horton, WA .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (04) :251-253
[8]   Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture [J].
Délot, E ;
Brodie, SG ;
King, LM ;
Wilcox, WR ;
Cohn, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26692-26697
[9]   CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) IS AN ABUNDANT COMPONENT OF TENDON [J].
DICESARE, P ;
HAUSER, N ;
LEHMAN, D ;
PASUMARTI, S ;
PAULSSON, M .
FEBS LETTERS, 1994, 354 (02) :237-240
[10]   Pseudoachondroplasia is caused through both intra-and extracellular pathogenic pathways [J].
Dinser, R ;
Zaucke, F ;
Kreppel, F ;
Hultenby, K ;
Kochanek, S ;
Paulsson, M ;
Maurer, P .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :505-513